1 Study Coverage 1.1 Gram-positive Bacterial Infection Drugs Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Introduction 1.2 Global Gram-positive Bacterial Infection Drugs Outlook 2017 VS 2022 VS 2028 1.2.1 Global Gram-positive Bacterial Infection Drugs Market Size for the Year 2017-2028 1.2.2 Global Gram-positive Bacterial Infection Drugs Market Size for the Year 2017-2028 1.3 Gram-positive Bacterial Infection Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Gram-positive Bacterial Infection Drugs in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Gram-positive Bacterial Infection Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Gram-positive Bacterial Infection Drugs Market Dynamics 1.4.1 Gram-positive Bacterial Infection Drugs Industry Trends 1.4.2 Gram-positive Bacterial Infection Drugs Market Drivers 1.4.3 Gram-positive Bacterial Infection Drugs Market Challenges 1.4.4 Gram-positive Bacterial Infection Drugs Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Gram-positive Bacterial Infection Drugs by Type 2.1 Gram-positive Bacterial Infection Drugs Market Segment by Type 2.1.1 Antibiotic 2.1.2 Antifungal 2.1.3 Others 2.2 Global Gram-positive Bacterial Infection Drugs Market Size by Type (2017, 2022 & 2028) 2.3 Global Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028) 2.4 United States Gram-positive Bacterial Infection Drugs Market Size by Type (2017, 2022 & 2028) 2.5 United States Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028) 3 Gram-positive Bacterial Infection Drugs by Application 3.1 Gram-positive Bacterial Infection Drugs Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Retail Pharmacies 3.1.3 Online Pharmacies 3.2 Global Gram-positive Bacterial Infection Drugs Market Size by Application (2017, 2022 & 2028) 3.3 Global Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028) 3.4 United States Gram-positive Bacterial Infection Drugs Market Size by Application (2017, 2022 & 2028) 3.5 United States Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028) 4 Global Gram-positive Bacterial Infection Drugs Competitor Landscape by Company 4.1 Global Gram-positive Bacterial Infection Drugs Market Size by Company 4.1.1 Top Global Gram-positive Bacterial Infection Drugs Companies Ranked by Revenue (2021) 4.1.2 Global Gram-positive Bacterial Infection Drugs Revenue by Player (2017-2022) 4.2 Global Gram-positive Bacterial Infection Drugs Concentration Ratio (CR) 4.2.1 Gram-positive Bacterial Infection Drugs Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Gram-positive Bacterial Infection Drugs in 2021 4.2.3 Global Gram-positive Bacterial Infection Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Gram-positive Bacterial Infection Drugs Headquarters, Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Type 4.3.1 Global Gram-positive Bacterial Infection Drugs Headquarters and Area Served 4.3.2 Global Gram-positive Bacterial Infection Drugs Companies Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Gram-positive Bacterial Infection Drugs Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Gram-positive Bacterial Infection Drugs Market Size by Company 4.5.1 Top Gram-positive Bacterial Infection Drugs Players in United States, Ranked by Revenue (2021) 4.5.2 United States Gram-positive Bacterial Infection Drugs Revenue by Players (2020, 2021 & 2022) 5 Global Gram-positive Bacterial Infection Drugs Market Size by Region 5.1 Global Gram-positive Bacterial Infection Drugs Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Gram-positive Bacterial Infection Drugs Market Size by Region (2017-2028) 5.2.1 Global Gram-positive Bacterial Infection Drugs Market Size by Region: 2017-2022 5.2.2 Global Gram-positive Bacterial Infection Drugs Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028 6.1.2 North America Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028 6.3.2 Europe Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028 6.4.2 Latin America Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Details 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Gram-positive Bacterial Infection Drugs Introduction 7.1.4 Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.1.5 Pfizer Recent Development 7.2 Sanofi 7.2.1 Sanofi Company Details 7.2.2 Sanofi Business Overview 7.2.3 Sanofi Gram-positive Bacterial Infection Drugs Introduction 7.2.4 Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.2.5 Sanofi Recent Development 7.3 GlaxoSmithKline 7.3.1 GlaxoSmithKline Company Details 7.3.2 GlaxoSmithKline Business Overview 7.3.3 GlaxoSmithKline Gram-positive Bacterial Infection Drugs Introduction 7.3.4 GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.3.5 GlaxoSmithKline Recent Development 7.4 Bayer 7.4.1 Bayer Company Details 7.4.2 Bayer Business Overview 7.4.3 Bayer Gram-positive Bacterial Infection Drugs Introduction 7.4.4 Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.4.5 Bayer Recent Development 7.5 Bristol-Myers Squibb 7.5.1 Bristol-Myers Squibb Company Details 7.5.2 Bristol-Myers Squibb Business Overview 7.5.3 Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Introduction 7.5.4 Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.5.5 Bristol-Myers Squibb Recent Development 7.6 Novartis 7.6.1 Novartis Company Details 7.6.2 Novartis Business Overview 7.6.3 Novartis Gram-positive Bacterial Infection Drugs Introduction 7.6.4 Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.6.5 Novartis Recent Development 7.7 Merck 7.7.1 Merck Company Details 7.7.2 Merck Business Overview 7.7.3 Merck Gram-positive Bacterial Infection Drugs Introduction 7.7.4 Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.7.5 Merck Recent Development 7.8 AstraZeneca 7.8.1 AstraZeneca Company Details 7.8.2 AstraZeneca Business Overview 7.8.3 AstraZeneca Gram-positive Bacterial Infection Drugs Introduction 7.8.4 AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.8.5 AstraZeneca Recent Development 7.9 Allergan 7.9.1 Allergan Company Details 7.9.2 Allergan Business Overview 7.9.3 Allergan Gram-positive Bacterial Infection Drugs Introduction 7.9.4 Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.9.5 Allergan Recent Development 7.10 Theravance Biopharma 7.10.1 Theravance Biopharma Company Details 7.10.2 Theravance Biopharma Business Overview 7.10.3 Theravance Biopharma Gram-positive Bacterial Infection Drugs Introduction 7.10.4 Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) 7.10.5 Theravance Biopharma Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Gram-positive Bacterial Infection Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Gram-positive Bacterial Infection Drugs Market Trends Table 3. Gram-positive Bacterial Infection Drugs Market Drivers Table 4. Gram-positive Bacterial Infection Drugs Market Challenges Table 5. Gram-positive Bacterial Infection Drugs Market Restraints Table 6. Global Gram-positive Bacterial Infection Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Gram-positive Bacterial Infection Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Gram-positive Bacterial Infection Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Gram-positive Bacterial Infection Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Gram-positive Bacterial Infection Drugs Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Gram-positive Bacterial Infection Drugs Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Gram-positive Bacterial Infection Drugs Revenue Share by Player, 2017-2022 Table 13. Global Gram-positive Bacterial Infection Drugs Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Gram-positive Bacterial Infection Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gram-positive Bacterial Infection Drugs as of 2021) Table 15. Top Players of Gram-positive Bacterial Infection Drugs in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Gram-positive Bacterial Infection Drugs Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Gram-positive Bacterial Infection Drugs Players in United States Market, Ranking by Revenue (2021) Table 20. United States Gram-positive Bacterial Infection Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Gram-positive Bacterial Infection Drugs Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Gram-positive Bacterial Infection Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Gram-positive Bacterial Infection Drugs Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Gram-positive Bacterial Infection Drugs Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Gram-positive Bacterial Infection Drugs Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Pfizer Company Details Table 31. Pfizer Business Overview Table 32. Pfizer Gram-positive Bacterial Infection Drugs Product Table 33. Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 34. Pfizer Recent Development Table 35. Sanofi Company Details Table 36. Sanofi Business Overview Table 37. Sanofi Gram-positive Bacterial Infection Drugs Product Table 38. Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 39. Sanofi Recent Development Table 40. GlaxoSmithKline Company Details Table 41. GlaxoSmithKline Business Overview Table 42. GlaxoSmithKline Gram-positive Bacterial Infection Drugs Product Table 43. GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 44. GlaxoSmithKline Recent Development Table 45. Bayer Company Details Table 46. Bayer Business Overview Table 47. Bayer Gram-positive Bacterial Infection Drugs Product Table 48. Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 49. Bayer Recent Development Table 50. Bristol-Myers Squibb Company Details Table 51. Bristol-Myers Squibb Business Overview Table 52. Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Product Table 53. Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 54. Bristol-Myers Squibb Recent Development Table 55. Novartis Company Details Table 56. Novartis Business Overview Table 57. Novartis Gram-positive Bacterial Infection Drugs Product Table 58. Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 59. Novartis Recent Development Table 60. Merck Company Details Table 61. Merck Business Overview Table 62. Merck Gram-positive Bacterial Infection Drugs Product Table 63. Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 64. Merck Recent Development Table 65. AstraZeneca Company Details Table 66. AstraZeneca Business Overview Table 67. AstraZeneca Gram-positive Bacterial Infection Drugs Product Table 68. AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 69. AstraZeneca Recent Development Table 70. Allergan Company Details Table 71. Allergan Business Overview Table 72. Allergan Gram-positive Bacterial Infection Drugs Product Table 73. Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 74. Allergan Recent Development Table 75. Theravance Biopharma Company Details Table 76. Theravance Biopharma Business Overview Table 77. Theravance Biopharma Gram-positive Bacterial Infection Drugs Product Table 78. Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Table 79. Theravance Biopharma Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Gram-positive Bacterial Infection Drugs Product Picture Figure 2. Global Gram-positive Bacterial Infection Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Gram-positive Bacterial Infection Drugs Market Size 2017-2028 (US$ Million) Figure 4. United States Gram-positive Bacterial Infection Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Gram-positive Bacterial Infection Drugs Market Size 2017-2028 (US$ Million) Figure 6. United States Gram-positive Bacterial Infection Drugs Market Share in Global 2017-2028 Figure 7. Gram-positive Bacterial Infection Drugs Report Years Considered Figure 8. Product Picture of Antibiotic Figure 9. Product Picture of Antifungal Figure 10. Product Picture of Others Figure 11. Global Gram-positive Bacterial Infection Drugs Market Share by Type in 2022 & 2028 Figure 12. Global Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Gram-positive Bacterial Infection Drugs Market Share by Type (2017-2028) Figure 14. United States Gram-positive Bacterial Infection Drugs Market Share by Type in 2022 & 2028 Figure 15. United States Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Gram-positive Bacterial Infection Drugs Market Share by Type (2017-2028) Figure 17. Product Picture of Hospital Pharmacies Figure 18. Product Picture of Retail Pharmacies Figure 19. Product Picture of Online Pharmacies Figure 20. Global Gram-positive Bacterial Infection Drugs Market Share by Application in 2022 & 2028 Figure 21. Global Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Gram-positive Bacterial Infection Drugs Market Share by Application (2017-2028) Figure 23. United States Gram-positive Bacterial Infection Drugs Market Share by Application in 2022 & 2028 Figure 24. United States Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Gram-positive Bacterial Infection Drugs Market Share by Application (2017-2028) Figure 26. North America Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. U.A.E Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Pfizer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 55. Sanofi Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 56. GlaxoSmithKline Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 57. Bayer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 59. Novartis Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 60. Merck Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 61. AstraZeneca Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 62. Allergan Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 63. Theravance Biopharma Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Pfizer Sanofi GlaxoSmithKline Bayer Bristol-Myers Squibb Novartis Merck AstraZeneca Allergan Theravance Biopharma